Results 181 to 190 of about 11,256 (207)

A One-Pot Radiosynthesis of [18F]PARPi

Journal of Labelled Compounds and Radiopharmaceuticals, 2020
Thomas C Wilson, Nagavarakishore Pillarsetty, Thomas Reiner   +2 more
exaly  

Radiosensitization of chondrosarcoma cells with PARPi

2023
Gilbert, Antoine, Chevalier, François
openaire   +1 more source

Evaluation of hematologic parameters in patients on PARPi therapy

Gynecologic Oncology, 2020
Grace Duininck, Ana Valente, Chao Xu, Kathleen N. Moore   +3 more
openaire   +1 more source

Ovarialkarzinom: Erhaltung mit PARPi

Im Focus Onkologie, 2018
openaire   +1 more source

The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers

Molecular Cell, 2019
Youngho Kwon, Natalia Maverakis, Patrick Sung   +2 more
exaly  

USE OF ALC1 INHIBITORS AND SYNERGY WITH PARPI

2023
MENZER WILLIAM M, SAHIRI KATHARINA, SCHOMBURG ADRIAN, LADURNER ANDREAS, SENNHENN PETER   +4 more
openaire   +1 more source

Real-World Applications of PARPi Maintenance Therapy for Recurrent Ovarian Cancer: A Single-Center Study in China

Gynecologic Oncology, 2023
exaly  

Serial ctDNA to understand PARPi resistance

Nature Reviews Urology
openaire   +2 more sources

PARPi-FL FORMULATIONS

2022
openaire   +1 more source

569 The Leuven PARPi benefit test as improved approach for prediction of PARPi benefit in the PAOLA-1/ENGOTov25 trial

International Journal of Gynecological Cancer
Liselore Loverix, Ignace Vergote, Pieter Busschaert, Tom Venken, Philipp Harter, Els Van Nieuwenhuysen, Sandro Pignata, Thaïs Baert, Antonio Gonzalez-Martin, Sileny Han, Christian Marth, Patrick Neven, Nicoletta Colombo, Toon Van Putte, Patrick Berteloot, Johanna Mäenpäa, Isabelle Ray-Coquard, Eric Pujade-Lauraine, Diether Lambrechts, Toon Van Gorp   +19 more
openaire   +1 more source